SCHEMBL19735752

SCHEMBL19735752

N#Cc1cc(F)c(N2CCC[C@H](NC(=O)OCc3ccccc3)C2)c2c1[nH]c1ccccc12

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BTK Q06187 19/20 0.55
CTSL P07711 1/20 0.47
CTSB P07858 1/20 0.47
CTSK P43235 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21509090 1.00 BTK (0.55) BTKCTSLCTSBCTSK
SCHEMBL19715442 0.89 BTK (0.61) BTK
SCHEMBL19279046 0.89 BTK (0.61) BTK
SCHEMBL20863093 0.88 BTK (0.54) BTKCTSLCTSBCTSK
SCHEMBL17707905 0.88 BTK (0.54) BTKCTSLCTSBCTSK
SCHEMBL29782655 0.88 BTK (0.54) BTKCTSLCTSBCTSK
SCHEMBL19715379 0.87 BTK (0.57) BTK
SCHEMBL21508948 0.87 BTK (0.57) BTK
SCHEMBL19715332 0.87 BTK (0.57) BTK
SCHEMBL28372380 0.84 BTK (0.48) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053197-B2 Carbazole derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2021-07-06 US disclosed
US-20200255377-A1 CARBAZOLE DERIVATIVES Organization Name: BRISTOL-MYERS SQUIBB COMPANY (US) 2020-08-13 US disclosed
US-10676434-B2 Carbazole derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2020-06-09 US disclosed
EP-3209651-B9 CARBAZOLE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2020-05-20 EP disclosed
CN-107074804-B Carbazole derivatives 百时美施贵宝公司 2020-02-18 CN disclosed
EP-3209651-B1 CARBAZOLE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2019-10-23 EP disclosed
US-20190225583-A1 CARBAZOLE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2019-07-25 US disclosed
US-10266491-B2 Carbazole derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2019-04-23 US disclosed
US-20170362176-A1 CARBAZOLE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266491-B2 Carbazole derivatives BTK, SYK, JAK2 BTK 1/4885CTSL 3921/4885CTSB 1259/4885
US-10676434-B2 Carbazole derivatives BTK, SYK, JAK2 BTK 1/4885CTSL 3766/4885CTSB 1208/4885
US-20170362176-A1 CARBAZOLE DERIVATIVES BTK, SYK, JAK2 BTK 1/4885CTSL 3921/4885CTSB 1259/4885
US-11053197-B2 Carbazole derivatives BTK, SYK, JAK2 BTK 1/4885CTSL 3766/4885CTSB 1208/4885
US-20190225583-A1 CARBAZOLE DERIVATIVES BTK, SYK, JAK2 BTK 1/4885CTSL 3766/4885CTSB 1208/4885
US-20200255377-A1 CARBAZOLE DERIVATIVES BTK, SYK, JAK2 BTK 1/4885CTSL 3766/4885CTSB 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.